Literature DB >> 29351117

Associations of Comorbid Anxiety With Medication Adherence and Psychiatric Symptomatology in a Population of Nonadherent Bipolar Disorder Subjects.

Awais Aftab, Jennifer Levin, Michelle Aebi, Chetan Bhat, Martha Sajatovic.   

Abstract

This analysis was conducted on baseline data from 178 nonadherent bipolar disorder subjects in a randomized controlled trial. Medication adherence was measured with Tablets Routine Questionnaire as percentage of days with missed doses. Inclusion criteria required at least 20% nonadherence. Medication adherence, symptomatology, and functioning in individuals with and without a comorbid anxiety disorder were compared. There were 78.9% of subjects who had at least one or more current anxiety disorder, with the most common being posttraumatic stress disorder, panic disorder, and generalized anxiety disorder. The percentage of days with missed doses over the past month was significantly lower in those with anxiety disorders compared with those without (40.1% vs 50.5%, p = 0.03). Those with comorbid anxiety disorders and those with greater number of anxiety disorder diagnoses had significantly worse mean scores on the Montgomery-Åsberg Depression Rating Scale, Brief Psychiatric Rating Scale, Clinical Global Impression-Bipolar Version, and Global Assessment of Functioning.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29351117      PMCID: PMC5876117          DOI: 10.1097/NMD.0000000000000788

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  37 in total

1.  Nonadherence with mood stabilizers: prevalence and predictors.

Authors:  Jan Scott; Marie Pope
Journal:  J Clin Psychiatry       Date:  2002-05       Impact factor: 4.384

2.  Self-reported medication treatment adherence among veterans with bipolar disorder.

Authors:  Martha Sajatovic; Mark S Bauer; Amy M Kilbourne; Julia E Vertrees; William Williford
Journal:  Psychiatr Serv       Date:  2006-01       Impact factor: 3.084

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

Authors:  M K Spearing; R M Post; G S Leverich; D Brandt; W Nolen
Journal:  Psychiatry Res       Date:  1997-12-05       Impact factor: 3.222

5.  Patient and physician attitudes toward lithium: relationship to compliance.

Authors:  K R Jamison; R H Gerner; F K Goodwin
Journal:  Arch Gen Psychiatry       Date:  1979-07-20

6.  The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998.

Authors:  C E Begley; J F Annegers; A C Swann; C Lewis; S Coan; W B Schnapp; L Bryant-Comstock
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

7.  The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder.

Authors:  Naomi M Simon; Alyson K Zalta; Michael W Otto; Michael J Ostacher; Diana Fischmann; Candice W Chow; Elizabeth H Thompson; Julie C Stevens; Christina M Demopulos; Andrew A Nierenberg; Mark H Pollack
Journal:  J Psychiatr Res       Date:  2006-10-18       Impact factor: 4.791

Review 8.  Generalised anxiety disorder in elderly patients : epidemiology, diagnosis and treatment options.

Authors:  Alastair J Flint
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

9.  Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders - an 18-month prospective study.

Authors:  Petri Arvilommi; Kirsi Suominen; Outi Mantere; Sami Leppämäki; Hanna Valtonen; Erkki Isometsä
Journal:  J Affect Disord       Date:  2013-10-28       Impact factor: 4.839

Review 10.  Costs of bipolar disorder.

Authors:  Leah Kleinman; Ana Lowin; Emuella Flood; Gian Gandhi; Eric Edgell; Dennis Revicki
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.